Form 4: Encompass Health Director Boosts Holdings via RSU Award

Encompass Health Director Greg D. Carmichael acquired 28 shares of common stock through a routine restricted stock unit award tied to a dividend payment.

Summary

• Director Greg D. Carmichael acquired 28 shares of Encompass Health Corp common stock.
• The acquisition occurred on January 15, 2026, at a price of $0 per share.
• This transaction was an award of Restricted Stock Units (RSUs) linked to a common stock dividend payment.
• On January 15, 2026, Encompass Health paid a dividend of $0.19 per share, with the closing stock price at $102.80.
• Following this transaction, Mr. Carmichael beneficially owns 18,659 shares of Encompass Health common stock.

Sentiment

Score: 6

Explanation: Slightly positive as a director is increasing holdings, even if through a routine RSU award, indicating continued alignment with shareholder interests.

Positives

• Director Greg D. Carmichael increased his beneficial ownership in Encompass Health by 28 shares, signaling continued alignment with shareholder interests.
• The acquisition is part of a routine RSU award program for non-employee directors, demonstrating a structured approach to executive compensation and retention.

Future Outlook

This filing is a factual report of an insider transaction and does not contain forward-looking statements or guidance regarding the company's future performance.

Industry Context

This routine insider transaction does not provide specific insights into broader industry trends within the healthcare sector. It reflects standard corporate governance practices for director compensation.

Stakeholder Impact

• Shareholders may view the director's increased holdings, even through a routine RSU award, as a positive signal of continued alignment between management and shareholder interests.

Key Dates

Recommendation

This Form 4 reports a routine acquisition of shares by a director through a Restricted Stock Unit award tied to a dividend. While it indicates continued alignment of interests, it is not a discretionary open-market purchase and therefore does not provide sufficient new information to warrant a change from a 'hold' recommendation based solely on this filing.

Keywords

Encompass Health, EHC, Insider Transaction, Form 4, Director Stock Acquisition, Restricted Stock Units, RSU, Dividend Reinvestment, Corporate Governance